FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034888835> ?p ?o ?g. }

• W2034888835 abstract "Background: Traditional diabetes therapies have been associated with weight gain, hypoglycemia, and/or high secondary failure rates. Glucagon-like peptide-1 (GLP-1) analog use is associated with a minimal risk of hypoglycemia, a persistent average weight loss of 2 to 3 kg, and sustained efficacy even after 3 years of use. Presently, 3 GLP-1 analogs are commercially available in the United States. Objective: To evaluate the real-world clinical utility of once weekly exenatide in type 2 diabetes mellitus (T2DM) patients who previously received once or twice daily GLP-1 therapy. Methods: In this pre–post observational study, electronic medical records (EMRs) were reviewed to identify patients meeting all study criteria. Data collected included baseline patient demographic information, duration of diabetes, disease states, medications, pertinent laboratory data, blood pressure, height, weight, and reported adverse drug events. Primary (changes in A1C and percentage of patients reporting adverse effects of therapy) and secondary (percentage of patients with A1C of <7% and changes in weight, blood pressure, and lipids) outcomes were evaluated using appropriate statistical analysis. Results: EMRs of 78 patients met all study criteria. Baseline patient demographic information included an average age of 61 ± 12 years, an average duration of T2DM of 14 ± 6 years, 59% of patients were male, and 93.6% were Caucasian. The baseline average body mass index was 39 ± 9.2, and mean A1C was 7.47 ± 1.45%. After a minimum of 3 months (average = 5.6 months) switchover, there were significant decreases in A1C (−0.35%; P = .0067) and weight (−1.6 kg; P = .0151). There were no significant changes in blood pressure or lipid levels. Two patients (2.5%) discontinued once weekly exenatide due to adverse reactions. Conclusion: Once weekly exenatide was generally well tolerated and significantly reduced A1C levels and body weight in patients with T2DM when switched from a shorter-acting GLP-1 analog." @default.
• W2034888835 created "2016-06-24" @default.
• W2034888835 creator A5000942604 @default.
• W2034888835 creator A5038468673 @default.
• W2034888835 creator A5061042244 @default.
• W2034888835 creator A5072828158 @default.
• W2034888835 creator A5073143328 @default.
• W2034888835 creator A5074380046 @default.
• W2034888835 creator A5076763983 @default.
• W2034888835 date "2014-01-07" @default.
• W2034888835 modified "2023-09-23" @default.
• W2034888835 title "Weekly Exenatide Therapy" @default.
• W2034888835 cites W1968426988 @default.
• W2034888835 cites W1975756049 @default.
• W2034888835 cites W1977102586 @default.
• W2034888835 cites W1978518803 @default.
• W2034888835 cites W1999843320 @default.
• W2034888835 cites W2008132861 @default.
• W2034888835 cites W2016193795 @default.
• W2034888835 cites W2031891480 @default.
• W2034888835 cites W2043900831 @default.
• W2034888835 cites W2065319712 @default.
• W2034888835 cites W2083357334 @default.
• W2034888835 cites W2093738306 @default.
• W2034888835 cites W2096483973 @default.
• W2034888835 cites W2103023541 @default.
• W2034888835 cites W2113367996 @default.
• W2034888835 cites W2123946565 @default.
• W2034888835 cites W2129934471 @default.
• W2034888835 cites W2135692247 @default.
• W2034888835 cites W2138077952 @default.
• W2034888835 cites W2152984355 @default.
• W2034888835 cites W2159112515 @default.
• W2034888835 cites W2159198773 @default.
• W2034888835 cites W2170606300 @default.
• W2034888835 cites W2188846692 @default.
• W2034888835 cites W2322256252 @default.
• W2034888835 cites W2337454357 @default.
• W2034888835 doi "https://doi.org/10.1177/8755122513518189" @default.
• W2034888835 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5990137" @default.
• W2034888835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34860898" @default.
• W2034888835 hasPublicationYear "2014" @default.
• W2034888835 type Work @default.
• W2034888835 sameAs 2034888835 @default.
• W2034888835 citedByCount "0" @default.
• W2034888835 crossrefType "journal-article" @default.
• W2034888835 hasAuthorship W2034888835A5000942604 @default.
• W2034888835 hasAuthorship W2034888835A5038468673 @default.
• W2034888835 hasAuthorship W2034888835A5061042244 @default.
• W2034888835 hasAuthorship W2034888835A5072828158 @default.
• W2034888835 hasAuthorship W2034888835A5073143328 @default.
• W2034888835 hasAuthorship W2034888835A5074380046 @default.
• W2034888835 hasAuthorship W2034888835A5076763983 @default.
• W2034888835 hasBestOaLocation W20348888352 @default.
• W2034888835 hasConcept C126322002 @default.
• W2034888835 hasConcept C134018914 @default.
• W2034888835 hasConcept C177713679 @default.
• W2034888835 hasConcept C2777180221 @default.
• W2034888835 hasConcept C2778881409 @default.
• W2034888835 hasConcept C2780533449 @default.
• W2034888835 hasConcept C555293320 @default.
• W2034888835 hasConcept C71924100 @default.
• W2034888835 hasConcept C98274493 @default.
• W2034888835 hasConceptScore W2034888835C126322002 @default.
• W2034888835 hasConceptScore W2034888835C134018914 @default.
• W2034888835 hasConceptScore W2034888835C177713679 @default.
• W2034888835 hasConceptScore W2034888835C2777180221 @default.
• W2034888835 hasConceptScore W2034888835C2778881409 @default.
• W2034888835 hasConceptScore W2034888835C2780533449 @default.
• W2034888835 hasConceptScore W2034888835C555293320 @default.
• W2034888835 hasConceptScore W2034888835C71924100 @default.
• W2034888835 hasConceptScore W2034888835C98274493 @default.
• W2034888835 hasLocation W20348888351 @default.
• W2034888835 hasLocation W20348888352 @default.
• W2034888835 hasLocation W20348888353 @default.
• W2034888835 hasLocation W20348888354 @default.
• W2034888835 hasOpenAccess W2034888835 @default.
• W2034888835 hasPrimaryLocation W20348888351 @default.
• W2034888835 hasRelatedWork W188703145 @default.
• W2034888835 hasRelatedWork W1911078937 @default.
• W2034888835 hasRelatedWork W1964059797 @default.
• W2034888835 hasRelatedWork W1966991896 @default.
• W2034888835 hasRelatedWork W1969181381 @default.
• W2034888835 hasRelatedWork W1995257796 @default.
• W2034888835 hasRelatedWork W1996602059 @default.
• W2034888835 hasRelatedWork W2023891261 @default.
• W2034888835 hasRelatedWork W2035966484 @default.
• W2034888835 hasRelatedWork W2059228484 @default.
• W2034888835 hasRelatedWork W2086521803 @default.
• W2034888835 hasRelatedWork W2105812875 @default.
• W2034888835 hasRelatedWork W2138965855 @default.
• W2034888835 hasRelatedWork W2340579837 @default.
• W2034888835 hasRelatedWork W2345628683 @default.
• W2034888835 hasRelatedWork W2366970942 @default.
• W2034888835 hasRelatedWork W2419429039 @default.
• W2034888835 hasRelatedWork W2583639096 @default.
• W2034888835 hasRelatedWork W3031090650 @default.
• W2034888835 hasRelatedWork W2285786087 @default.
• W2034888835 isParatext "false" @default.
• W2034888835 isRetracted "false" @default.

• next